RNF144A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.59109947439617E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.26839982961258E-10 |
Normal-vs-Stage2 |
3.52960000000735E-05 |
Normal-vs-Stage3 |
6.82979999999667E-07 |
Normal-vs-Stage4 |
3.55830000000612E-05 |
Stage1-vs-Stage2 |
7.278800E-01 |
Stage1-vs-Stage3 |
8.311600E-01 |
Stage1-vs-Stage4 |
8.792200E-01 |
Stage2-vs-Stage3 |
8.863600E-01 |
Stage2-vs-Stage4 |
7.145800E-01 |
Stage3-vs-Stage4 |
7.730000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.33160199217764E-11 |
Normal-vs-AfricanAmerican |
6.83380000032763E-07 |
Normal-vs-Asian |
2.537500E-03 |
Caucasian-vs-AfricanAmerican |
2.339400E-01 |
Caucasian-vs-Asian |
8.527600E-01 |
AfricanAmerican-vs-Asian |
8.263000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.73683289972359E-12 |
Normal-vs-Female |
3.772700E-04 |
Male-vs-Female |
4.801700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.67449999982838E-07 |
Normal-vs-Extreme_Weight |
4.86930495924298E-11 |
Normal-vs-Obese |
1.21579999956545E-07 |
Normal-vs-Extreme_Obese |
1.68122999999465E-05 |
Normal_Weight-vs-Extreme_Weight |
4.376600E-01 |
Normal_Weight-vs-Obese |
8.675400E-01 |
Normal_Weight-vs-Extreme_Obese |
5.336000E-01 |
Extreme_Weight-vs-Obese |
3.174400E-01 |
Extreme_Weight-vs-Extreme_Obese |
7.574400E-01 |
Obese-vs-Extreme_Obese |
4.816800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.035200E-01 |
Normal-vs-Age(41-60Yrs) |
9.63659996244814E-09 |
Normal-vs-Age(61-80Yrs) |
1.50129908504937E-11 |
Normal-vs-Age(81-100Yrs) |
5.50739998050886E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.187400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.220400E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.986020E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.245900E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.435900E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.022030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
3.06469960520417E-10 |
Normal-VS-Type2 PRCC |
5.10702591327572E-15 |
Normal-VS-KIRP CIMP |
5.790200E-01 |
Normal-VS-Unclassified PRCC |
7.716800E-03 |
Type1 PRCC-VS-Type2 PRCC |
2.574300E-02 |
Type1 PRCC-VS-KIRP CIMP |
1.121900E-03 |
Type1 PRCC-VS-Unclassified PRCC |
1.299610E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.52269999997845E-06 |
Type2 PRCC-VS-Unclassified PRCC |
1.578440E-02 |
KIRP CIMP-VS-Unclassified PRCC |
2.035800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.85270001959748E-09 |
Normal-vs-N1 |
4.039600E-03 |
Normal-vs-N2 |
3.652200E-02 |
N0-vs-N1 |
7.676500E-02 |
N0-vs-N2 |
4.189400E-01 |
N1-vs-N2 |
9.586800E-01 |
|
|